Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Report Overview
2023
Base Year
2017-2023
Historical Year
2024-2032
Forecast Year
Global Ovarian Cancer Diagnostics and Therapeutics Market Outlook
The global ovarian cancer diagnostics and therapeutics market is projected to expand at a CAGR of 9.7% during the forecast period of 2024-2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The growing geriatric population and increased awareness among people are driving the growth of the diagnostic and therapeutic industry for ovarian cancer globally.
Properties and Applications
Ovarian cancer is the fourth most prevalent cause of death from cancer in females worldwide, and the tenth most prevalent cancer among females in the U.S. Ovarian cancer incidences are high in females belonging to the age group of 54-65 years. Pelvic, bloating, and abdominal pain, eating trouble, and urinary symptoms are the main causes of ovarian cancer.
Ovarian diagnostics and therapeutics are used to detect, treat, and heal ovarian cancer. The global ovarian cancer diagnostics and therapeutics industry can be segmented into cancer type and modality.
The industry is divided based on its cancer type as epithelial ovarian tumours and ovarian germ cell tumours, among others.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The industry is broadly categorised based on its modality into:
- Diagnosis
- Biopsy
- Blood Tests
- Ultrasound
- PET
- CT Scan
- Others
- Therapeutics
- Chemotherapy
- Radiation Therapy
- Immunotherapy
- Hormonal Therapy
- Others
The EMR report looks into the regional markets of ovarian cancer diagnostics and therapeutics like North America, Latin America, the Asia Pacific, Europe, and the Middle East and Africa.
Market Analysis
The increasing incidences of ovarian cancer worldwide, the use of combination therapies for the treatment of ovarian cancer, and the rising geriatric population are some of the major factors accelerating the growth of the ovarian cancer diagnostics and therapeutics industry globally. The absence of accurate techniques to diagnose ovarian cancer and the lack of awareness regarding cancer detection and treatment in emerging and low-income economies are the major drawbacks that may affect the industry growth over the forecast period.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Competitive Landscape
The report presents a detailed analysis of the following key players in the global ovarian cancer diagnostics and therapeutics market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
- AstraZeneca plc
- C.H. Boehringer Sohn AG & Ko. KG
- Bristol Myers Squibb Company
- Eli Lilly And Company
- F. Hoffmann-La Roche AG
- Others
The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Cancer Type |
|
| Breakup by Modality |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Looking for specific insights?
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Key Questions Answered in the Report
The global ovarian cancer diagnostics and therapeutics market is projected to grow at a CAGR of nearly 9.7% in the forecast period of 2024-2032.
The major drivers of the industry include the rising disposable incomes, increasing population, rising geriatric population, and the rising awareness about the cancer and its treatments among people.
The increased government funding and the surge in health care expenditure are expected to be the key trends guiding the growth of the industry.
North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa are the leading regions in the market.
The major cancer types in the industry include epithelial ovarian tumours and ovarian germ cell tumours, among others.
Diagnosis and therapeutics are the leading modality segments in the industry.
The leading players in the market are AstraZeneca plc, Boehringer Ingelheim, Bristol Myers Squibb Company, Eli Lilly And Company, Hoffman-La Roche Ltd, GlaxoSmithKline Plc, and Johnson And Johnson, among others.
Purchase Full Report
Datasheet
- Selected Sections, One User
- Printing Not Allowed
- Email Delivery in PDF
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Single User License
One User
- All Sections, One User
- One Print Allowed
- Email Delivery in PDF
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Five User License
Five Users
- All Sections, Five Users
- Five Prints Allowed
- Email Delivery in PDF
- Free Limited Customisation
- Post Sales Analyst Support
50% Discount on Next Update
Corporate License
Unlimited Users
- All Sections, Unlimited Users
- Unlimited Prints Allowed
- Email Delivery in PDF + Excel
- Free Limited Customisation
- Post Sales Analyst Support
- 50% Discount on Next Update
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Subscribe to our Newsletter
By subscribing you agree to with our privacy policy and provide
consent to
receive
updates
from our company.
Our Offices
Australia
63 Fiona Drive, Tamworth, NSW
+61 448 06 17 27
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63 287899028, +63 967 048 3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84865399124